Self-Stigma of Mental and Physical Health
1 other identifier
observational
823
1 country
1
Brief Summary
People with mental disorders often suffer from self-stigmatization. Self-stigma is associated with several negative outcomes such as low quality of life, lower rates of help-seeking as well as poorer treatment adherence. However, a lot of questionnaires only focus on specific mental disorders. There is no valid measurement which can be used for all kinds of mental disorders. Furthermore, much less is known about self-stigma in people with organic diseases. Only little attention has been given to those who may experience self-stigma because of their physical condition. A main reason for this may be the lack of a valid measurement of self-stigma among people with physical health issues. Therefore, the aim of this study is to develop and validate a self-report scale which is capable to do both - measuring self-stigma among people with all mental disorders and among people with physical health issues.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 4, 2019
CompletedFirst Submitted
Initial submission to the registry
May 6, 2020
CompletedFirst Posted
Study publicly available on registry
June 4, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2020
CompletedSeptember 16, 2021
September 1, 2021
8 months
May 6, 2020
September 14, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Development of the Universal Self-Stigma Scale (USSS)
Questionnaire is based on the Stereotype Content Model (Fiske et al., 2002) and BIAS-Map (Cuddy et al., 2007) and includes three components: stereotype (warmth, competence \[lower scores indicate higher self-stigma\]), prejudice (emotions, e.g. contempt, pity, anger, shame \[higher scores indicate higher self-stigma\]), discrimination (active/passive self-harm \[higher scores indicate higher self-stigma\]). Each item is rated on a 7-point Likert scale. Item selection via qualitative and statistical methods, e.g. item difficulty index, item discrimination index, exploratory factor analysis (EFA).
Baseline
Universal Self-Stigma Scale (USSS): Validity
Validation process includes confirmatory factor analysis (CFA) to test the statistical model fit with goodness of fit indices. Convergent validity is tested with another measurement for self-stigma (ISMI) using Pearson correlations \[higher correlations indicate better convergent validity\]. Discriminant validity is tested with Beck Depression Inventory-II (BDI-II) and public stigma \[lower correlations indicate better discriminant validity\], criterion validity with actual help seeking behavior and health related quality of life (12-Item Short-Form Health Survey, SF-12) using Pearson correlations as well \[higher correlations indicate better criterion validity\].
Baseline
Universal Self-Stigma Scale (USSS): Internal consistency
Internal consistency is tested with Cronbach's Alpha (0-1; higher scores indicate better internal consistency)
Baseline
Change on Universal Self-Stigma Scale (USSS): Test-Retest Reliability
Test-Retest Reliability (Pearson Correlation, 0-1; higher scores indicate better reliability)
Baseline and 4 weeks
Secondary Outcomes (7)
Intention to Seek Help
Baseline
Actual Help Seeking Behavior
Baseline and 4 weeks
12-Item Short-Form Health Survey (SF-12)
Baseline
Patient Health Questionnaire (PHQ)
Baseline
Beck Depression Inventory-II (BDI-II)
Baseline
- +2 more secondary outcomes
Study Arms (4)
healthy
Healthy participants
mentally ill
Participants with mental disorders
physically ill
Participants with organic disease
mentally and physically ill
Participants with mental disorders and organic disease
Eligibility Criteria
Random sample including students, outpatients, inpatients
You may qualify if:
- Minimum Age: 18
- Fluent in German Language
You may not qualify if:
- Acute psychosis
- Suicidal ideation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Clinical Psychology and Psychotherapy, Philipps-University Marburg
Marburg, 35032, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 6, 2020
First Posted
June 4, 2020
Study Start
November 4, 2019
Primary Completion
June 30, 2020
Study Completion
July 30, 2020
Last Updated
September 16, 2021
Record last verified: 2021-09